IP Library Assignment 015972/0603
Patent Assignment
Reel/Frame 015972/0603

Certificate of Domestication: Incorporation in Delaware

Recorded: 2005-03-30 Pages: 8
Assignor
PHARMASSET, LTD.
Executed: 2004-06-08
Assignee
PHARMASSET, INC.
1860 MONTREAL ROAD, TUCKER, GEORGIA, 30084
Covered Properties (45)
Tetraphosphonate Bicyclic Trisanhtdrides
Patent: 6,326,490 →
Application: 08/949,180 →
2'-deoxy-L-nucleosides
Application: 09/712,481 →
3'-Or 2'-Hydroxymethyl Substituted Nucleoside Derivatives for Treatment of Hepatites Virus Infections
Patent: 7,094,770 →
Application: 09/834,596 →
Publication: US 2002/0055483
Simultaneous quantification of nucleic acids in diseased cells
Application: 10/008,140 →
Publication: US 2003/0124512
Tetraphosphonate Bicyclic Trisanhydrides
Patent: 6,713,623 →
Application: 10/008,572 →
Publication: US 2002/0161220
Antiviral agents for treatment of Flaviviridae infections
Application: 10/023,637 →
Publication: US 2004/0266723
Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
Application: 10/045,292 →
Publication: US 2003/0087873
Method for the Synthesis of 2',3'-Dideoxy-2',3'-Didehydronucleosides
Patent: 6,927,291 →
Application: 10/087,112 →
Publication: US 2002/0198224
Beta-2'-Or 3'-Halonucleosides
Patent: 6,949,522 →
Application: 10/179,612 →
Publication: US 2005/0119286
N4-Acylcytosine Nucleosides for Treatment of Viral Infections
Patent: 7,105,527 →
Application: 10/318,511 →
Publication: US 2004/0214844
Preparation of intermediates useful in the synthesis of antiviral nucleosides
Application: 10/318,982 →
Publication: US 2003/0162992
N4-Acylcytosine-1,3- Dioxolane Nucleosides for Treatment of Viral Infections
Patent: 6,908,924 →
Application: 10/320,350 →
Publication: US 2003/0176319
Treatment of Ebv and Khsv Infection
Patent: 7,211,570 →
Application: 10/326,444 →
Publication: US 2003/0176392
Modified Fluorinated Nucleoside Analogues
Application: 10/366,144 →
Publication: US 2004/0002476
Dosing regimen for gemcitabine HCV therapy
Application: 10/367,388 →
Publication: US 2003/0225029
2', 3'-Dideoxynucleoside analogues for the treatment or prevention of Flaviviridae infections
Application: 10/632,875 →
Publication: US 2004/0067877
Compounds with the Bicyclo[4.2.1]Nonane System for the Treatment of Flavivridae Infections
Patent: 8,093,380 →
Application: 10/632,997 →
Publication: US 2004/0082574
Processes for Preparing 1,3-Dioxolane Nucleosides
Patent: 6,855,821 →
Application: 10/635,971 →
Publication: US 2004/0087806
Tetraphosphonate bicyclic trisanhydrides
Application: 10/812,214 →
Publication: US 2004/0181078
Compounds for the treatment of flaviviridae infections
Application: 10/812,448 →
Publication: US 2005/0049204
Simultaneous quantification of nucleic acids in diseased cells
Application: 10/854,870 →
Publication: US 2007/0031824
Dosing regimen for Flaviviridae therapy
Application: 10/921,052 →
Publication: US 2005/0049220
2'-deoxy-L-nucleosides
Application: 10/996,875 →
Publication: US 2005/0090660
Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
Application: 11/008,693 →
Publication: US 2005/0244490
Synthesis of 2'-Deoxy-L-Nucleosides
Application: 60/165,087 →
Nucleosides bearing a hydroxymethyl group at the 3'-or 2'- position or their analogues and derivatives for treatment of viral infection or proliferative diseases
Application: 60/197,068 →
Nucleosides bearing a hydroxymethyl group at the 3'- or 2'- position or their analogues and derivatives for treatment of viral infection or proliferative diseases
Application: 60/202,663 →
3'-deoxy and 3'-halo nucleosides for the treatment of flaviviridae infections
Application: 60/241,488 →
Antiviral agents for treatment of flaviviridae infections
Application: 60/256,066 →
Using real-time PCR to determine anti-HIV activity and mitochondrial toxicity of nucleoside analogs
Application: 60/256,067 →
Synthesis of a Beta-D-D4FC from 5-fluorocytidine
Application: 60/272,434 →
Synthesis of Beta-D-D4FC from 5-fluorouridine
Application: 60/272,441 →
Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
Application: 60/282,156 →
60300121Beta-2' or 3' -halonucleosides
Application: 60/300,356 →
Beta-2' - or 3' -halonucleosides
Application: 60/305,386 →
Preparation of intermediates useful in the synthesis of antiviral nucleosides
Application: 60/341,378 →
N4-acylcytosine nucleosides for treatment of viral infections
Application: 60/341,555 →
Nucleosides for treatment of epstein-barr virus and cytotoxic gene therapy
Application: 60/345,130 →
Modified fluorinated nucleoside analogues
Application: 60/357,411 →
Modified fluorinated nucleoside analogues
Application: 60/358,140 →
Processes for preparing 1,3-dioxolane nucleosides
Application: 60/401,655 →
2',3' -Dideoxynucleoside analogues for the treatment or prevention of flaviviridae infections
Application: 60/453,715 →
Compounds with the bicyclo[4.2.1]nonane system for the treatment of Flaviviridae infections
Application: 60/453,716 →
Dosing regimen for HCV therapy
Application: 60/496,202 →
Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5'-fluorocytidine antiviral therapy
Application: 60/528,138 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 10, 1997
From: PANKIEWICZ, KRZYSZTOF W.; LESIAK, KRYSTYNA; WATANABE, KYOICHI A.
To: CODON PHARMACEUTICALS, INC.
Reel/Frame 008776/0007 →
Assignment of Assignor's Interest Jun 25, 2001
From: WATANABE, KYOICHI A.; PAI, S. BALAKRISHNA
To: PHARMASSET, LTD.
Reel/Frame 011921/0663 →
Assignment of Assignor's Interest Feb 19, 2002
From: STUYVER, LIEVEN; WATANABE, KYOICHI A.
To: PHARMASSET, LTD.
Reel/Frame 012656/0520 →
Assignment of Assignor's Interest Feb 27, 2002
From: STUYVER, LIEVEN; PANKIEWICZ, KRYSZTOF W.; PATTERSON, STEVE; WATANABE, KYOICHI A.
To: PHARMASSET, LTD.
Reel/Frame 012652/0831 →
Assignment of Assignor's Interest Apr 11, 2002
From: STUYVER, LIEVEN; OTTO, MICHAEL J.
To: PHARMASSET, LTD.; FINANCIAL SERVICES CENTER
Reel/Frame 012794/0357 →
Assignment of Assignor's Interest Jul 23, 2002
From: JIN, FUQIANG; CONFALONE, PASQUALE N.
To: PHARMASSET, LTD.
Reel/Frame 013107/0111 →
Assignment of Assignor's Interest Dec 12, 2002
From: WATANABE, KYOICHI A.; DU, JINFA
To: PHARMASSET, LTD.
Reel/Frame 013593/0148 →
Assignment of Assignor's Interest Apr 16, 2003
From: SHI, JUNXING; WATANABE, KYOICHI A.; OTTO, MICHAEL J.
To: PHARMASSET, LTD.
Reel/Frame 013970/0290 →
Assignment of Assignor's Interest Aug 28, 2003
From: FINGEROTH, JOYCE D.; GUSTAFSON, ERIK
To: BETH ISRAEL DEACONESS MEDICAL CENTER
Reel/Frame 014448/0657 →
Assignment of Assignor's Interest Sep 3, 2003
From: SCHINAZI, RAYMOND F.
To: EMORY UNIVERSITY
Reel/Frame 014448/0651 →
Assignment of Assignor's Interest Sep 3, 2003
From: SHI, JUNXING
To: PHARMASSET, LTD.
Reel/Frame 014448/0662 →
Assignment of Assignor's Interest Dec 5, 2003
From: WANG, PEIYUAN; STUYVER, LIEVEN J.; WATANABE, KYOICHI A.; HASSAN, ABDALLA
To: PHARMASSET, LTD.
Reel/Frame 014177/0043 →
Assignment of Assignor's Interest Nov 11, 2004
From: WATANABE, KYOICHI A.; DU, JINFA
To: PHARMASSET, LTD.
Reel/Frame 015372/0276 →
Assignment of Assignor's Interest May 26, 2006
From: OTTO, MICHAEL J.; STUYVER, LIEVEN
To: PHARMASSET, INC.
Reel/Frame 017704/0965 →
Assignment of Assignor's Interest Feb 14, 2007
From: STRIKER, ROBERT
To: LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 018888/0298 →
Assignment of Assignor's Interest Feb 14, 2007
From: SCHINAZI, RAYMOND
To: EMORY UNIVERSITY
Reel/Frame 018888/0257 →
Assignment of Assignor's Interest Feb 14, 2007
From: SHI, JUNXING
To: PHARMASSET, INC.
Reel/Frame 018888/0213 →
Assignment of Assignor's Interest Feb 14, 2007
From: STUYVER, LIEVEN J.; SHI, JUNXING; WATANABE, KYOICHI A.
To: PHARMASSET, LTD.
Reel/Frame 018887/0967 →
Change of Address (Rule 3.73B Statement) Jun 20, 2007
From: PHARMASSET, INC.
To: PHARMASSET, INC.
Reel/Frame 019448/0790 →
Confirmatory License Oct 21, 2008
From: UNIVERSITY OF GEORGIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021712/0114 →
Confirmatory License Jan 4, 2010
From: BETH ISRAEL DEACONESS MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023720/0671 →
Assignment of Assignor's Interest Jun 24, 2010
From: OTTO, MICHAEL J.; SHI, JUNXING; WATANABE, KYOICHI A.
To: PHARMASSET, INC.
Reel/Frame 024576/0711 →
Change of Name Apr 20, 2012
From: PHARMASSET, INC.
To: GILEAD PHARMASSET LLC
Reel/Frame 028081/0686 →
Certificate of Conversion from a Corporation to Limited Liability Corporation Mar 7, 2013
From: PHARMASSET, INC.
To: GILEAD PHARMASSET LLC
Reel/Frame 029940/0476 →
Change of Name Aug 20, 2013
From: PHARMASSET, INC.
To: GILEAD PHARMASSET LLC
Reel/Frame 031043/0540 →